Keep up to date on the latest medical news at MDLinx - FREE!


  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

FDA: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

  
  
  
  
  

FDA issues drug safety annoucement for multiple sclerosis drug Gilenya (fingolimod).

The U.S. Food and Drug Administration (FDA) has completed its evaluation of a report of a patient who died after the first dose of multiple sclerosis drug Gilenya (fingolimod). The agency also has evaluated additional clinical trial and postmarket data for Gilenya, including reports of patients who died of cardiovascular events or unknown causes. FDA could not definitively conclude that Gilenya was related to any of the deaths (see Data Summary, below). However, based on its reevaluation of the data, FDA remains concerned about the cardiovascular effects of Gilenya after the first dose. Data show that, although the maximum heart rate lowering effect of Gilenya usually occurs within 6 hours of the first dose, the maximum effect may occur as late as 20 hours after the first dose in some patients (See Data Summary).

For this reason, Gilenya is now contraindicated (FDA advises against its use) in patients with certain pre-existing or recent (within last 6 months) heart conditions or stroke, or who are taking certain antiarrhythmic medications. See CONTRAINDICATION section of the drug label2.

FDA continues to recommend that all patients starting Gilenya be monitored for signs of a slow heart rate (bradycardia) for at least 6 hours after the first dose. FDA is now recommending hourly pulse and blood pressure measurement for all patients starting Gilenya. Electrocardiogram (ECG or EKG) testing should be performed prior to dosing and at the end of the observation period. Cardiovascular monitoring should continue until any symptoms resolve.

Read full release here.

Trending Medical Articles

Wednesday, Apr 9, 2014
Medical Oncology, 04/09/2014 Ibrahim L, et al. – The aim of the present study was to assess the expression of livin on leukemic blasts of de novo childhood ALL and its relevance to clinical and hematological findings, and treatment outcome. This study suggests that livin expression could be a novel prognostic marker in childhood ALL thus it could be incorporated into patient...Read More
Wednesday, Apr 9, 2014
BMC Infectious Diseases, 04/09/2014 Dia N, et al. – The main aim of this study was to determine the prevalence and the diversity of respiratory viruses associated with ILI cases in adults over 50 years old in Senegal. This pilot study demonstrates a variety of respiratory viruses in the elderly. It also highlights a high prevalence of these viruses in this age group. The authors...Read More
Wednesday, Apr 9, 2014
The American Journal of Surgery, 04/09/2014 de Castro S, et al. – The present study evaluates the incidence of delirium and risk factors associated with delirium in elderly patients admitted to a general surgical ward. The incidence of delirium is high in elderly patients, especially after an acute admission, leading to an increase in length of hospital stay. To minimize delirium,...Read More
Thursday, Apr 10, 2014
European Journal of Cancer, 04/10/2014 Trudel D, et al. – The aim of the study was to determine the impact of IDC and LC on biochemical recurrence–free rate (bRFR) in a contemporary prostatectomy cohort. The authors demonstrate that the presence of any amount of LC/IDC is a significant prognostic factor after adjusting for Gleason score and T stage in determining patient outcome...Read More
Thursday, Apr 10, 2014
Journal of Medical Case Reports, 04/10/2014 Ekwunife CN, et al. – A 29–year–old Nigerian Igbo man presented with progressively worsening abdominal pain following a road traffic accident. He was a front–seat passenger traveling without a seat belt. On physical examination his abdomen was distended with guarding and rigidity. Perforation of Meckel's diverticulum is rarely...Read More